-
Mashup Score: 5Source: link.springer.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Source: link.springer.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Visual #Peritoneal Evaluation of Residual Disease After #Neoadjuvant #Chemotherapy in Advanced #OvarianCancer Patients: The VIPER Study https://t.co/WCAEROOptG #VisualAbstract @McMastersKelly https://t.co/i3mgWhewg5
-
-
Mashup Score: 0
BackgroundAlthough anaplastic lymphoma kinase tyrosine kinase inhibitors (ALK-TKIs) have impressive response in advanced lung adenocarcinoma with anaplastic lymphoma kinase (ALK) fusion, no guidelines point to the potential benefits of neoadjuvant ALK-TKIs for N3 unresectable locally advanced lung cancer. Current ongoing clinical trials mainly focus on the efficacy of neoadjuvant ALK-TKIs in…
Source: FrontiersCategories: Latest Headlines, PulmonologyTweet-
#Casereport: Complete #pathological admission in N3 unresectable locally advanced #lung #adenocarcinoma with a novel INTS10-ALK and EML4-ALK fusion after #neoadjuvant #crizotinib https://t.co/tLZ3RwIpc1 https://t.co/bbSvZ4bfCv
-
-
Mashup Score: 2Source: link.springer.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Change Impact of Body Composition During #Neoadjuvant #Chemoradiotherapy in Patients with Resectable and Borderline Resectable #Pancreatic Ductal #Adenocarcinoma Undergoing #Pancreatectomy https://t.co/VrVNk0cvfp #VisualAbstract @McMastersKelly https://t.co/J5URuHMdbA
-
-
Mashup Score: 0Source: link.springer.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Exposure to #Neoadjuvant Oxaliplatin-Containing Chemotherapy, Does it Effect #Intraperitoneal #HyperthermicChemotherapy Perfusion? https://t.co/HufJxoqTzQ #VisualAbstract @McMastersKelly https://t.co/ZLEVdctytB
-
-
Mashup Score: 2
In the DONIMI trial, a baseline IFN-γ signature enables prospective selection of patients who can benefit from anti-PD-1 monotherapy. In contrast to results of
Source: rupress.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Brief return to #melanoma from #MarchMadness: studies like this are essential to fully vetting new targets/medicines due to unanticipated toxicities. This does not minimize the #biomarker findings in this study of #neoadjuvant checkpoint inhibition https://t.co/1LMECiBl1X
-
-
Mashup Score: 1Source: link.springer.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Development and Validation of a Predictive Model of Therapeutic Effect in Patients with #Esophageal #SquamousCellCarcinoma Who Received #Neoadjuvant Treatment: A Nationwide Retrospective Study in Japan https://t.co/RZvEHRxAjX #VisualAbstract @McMastersKelly https://t.co/t1vaOOW8vE
-
-
Mashup Score: 0Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Read this article to earn #CME Credit: A team of researchers designed a research study to help determine the effectiveness of #adjuvant #chemotherapy after #neoadjuvant chemotherapy (NAC) followed by surgery specifically for #PDAC patients. Learn more: https://t.co/lceRkR1Xim https://t.co/XQFFRyLci7
-
-
Mashup Score: 0
In pivotal study, KEYTRUDA® (pembrolizumab) in combination with chemotherapy before surgery and continuing as a single agent after surgery showed a statistically significant improvement in EFS versus pre-operative chemotherapy KEYTRUDA-based regimen also showed statistically significant improvements in key secondary endpoints of pathological complete response and major pathological response FDA…
Source: Merck.comCategories: Hem/Oncs, Latest HeadlinesTweet-
🔥🚨@Merck Announces Phase 3 #KEYNOTE671 Trial of #NeoAdjuvant Pembrolizumab + Chemo, in Patients With Resectable Stage II, IIIA or IIIB Non-Small Cell #LungCancer, Met Primary Endpoint: #EFS. Results will be presented at upcoming meeting. #LCSM #NSCLC 👇🏼 https://t.co/jXoyvyafk7 https://t.co/0bgAaYfn8u
-
-
Mashup Score: 0Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Read this article to earn #CME Credit: A team of researchers designed a research study to help determine the effectiveness of #adjuvant #chemotherapy after #neoadjuvant chemotherapy (NAC) followed by surgery specifically for #PDAC patients. Learn more: https://t.co/lceRkR1Xim https://t.co/PIA8s2VSZD
-
The Absence of Cancer in the Location of a Breast Tissue Marker After #Neoadjuvant #Chemotherapy may Predict Pathological Complete Response with High Accuracy: Results from a Phase II Trial https://t.co/m1JbOPTREf #VisualAbstract @McMastersKelly https://t.co/jTrlIbAmRI